CUDOS: Clinically Useful Depression Outcome Scale

What this assessment is

The CUDOS, or Clinically Useful Depression Outcome Scale, records 16 depression-symptom ratings over the past week plus separate responses about functional interference and quality of life. Only the 16 symptom ratings form the total from 0 to 64. The other two responses are reviewed separately.

Mark Zimmerman and colleagues developed the 18-item form for routine clinical measurement, with the original validation describing a measure designed to take less than three minutes and remain sensitive to change.

The CUDOS measures symptom severity. It does not diagnose depression.

Who it was designed for

The original study tested psychiatric outpatients, including adults with and without depressive disorders, and designed the scale for repeated use during care.

It may help a clinician and patient see whether reported symptoms are changing. The same version, timeframe, language, and scoring method should be used at each measurement.

Evidence from psychiatric outpatient care does not automatically establish performance in every community, age group, or medical setting.

How it is administered

The CUDOS asks about the past week, including the day of completion, and its 16 symptom ratings use values from 0 to 4.

Two additional responses record functional interference and quality of life. They are not included in the symptom total.

The VA measurement toolkit describes an 18-item form that usually takes less than three minutes.

What it measures

The CUDOS covers symptoms associated with depression and records functional interference and quality of life separately.

One symptom total cannot show which symptom drove the result, while the two additional responses add context without changing that total.

The CUDOS was built around DSM-IV symptom descriptions. A current diagnosis requires a current clinical assessment, not a score conversion.

How scoring works

Add the 16 symptom responses, each worth 0 to 4 points, for a total from 0 to 64.

Higher totals indicate more frequent or severe reported depression-related symptoms during the past week. They do not include the two separate impact responses.

The published symptom score is a straight sum, but the sources reviewed for this page do not establish a universal missing-response rule.

Report whether the symptom responses are complete, and do not present an incomplete sum as a complete 0-to-64 score.

How to interpret a CUDOS score

The developers proposed these approximate ranges:

• 0 to 10: nondepressed range
• 11 to 20: minimal range
• 21 to 30: mild range
• 31 to 45: moderate range
• 46 to 64: severe range

These ranges came from the developers' data and clinical experience, and a developer-authored scoring paper presents them as approximations rather than diagnostic boundaries.

The label nondepressed does not rule out a depressive disorder. A score can also be affected by treatment, recent events, physical health, and the person's interpretation of the response choices.

Repeated totals can show direction of change when the same method is used. A smaller total suggests fewer reported symptoms, but it does not prove recovery.

A score does not replace a safety check

The CUDOS contains death- and suicide-related content. Any endorsement needs direct review, regardless of the total.

If you need help now. In the US, Call 988 or text 988. Call 911 if you are in immediate danger. Outside the US, contact your local emergency number or find support in your country.

A low total does not make a concerning response unimportant. Use a direct safety assessment and the applicable local emergency protocol.

What the score cannot tell you

The CUDOS cannot confirm or rule out a depressive disorder. It also cannot explain whether symptoms come from depression, grief, illness, medication, substance use, sleep disruption, or another condition.

It cannot choose treatment or determine urgency by itself. Clinical decisions require direct assessment of symptoms, function, history, safety, and context.

Evidence and limitations

The original study tested more than 1,400 psychiatric outpatients and found high reliability, expected correlations with other depression measures, and sensitivity to symptom change.

A later Korean validation study also found strong measurement properties in psychiatric outpatients. That study used a translated version and proposed a screening cutoff for its own sample.

The evidence supports measurement rather than automatic diagnosis, and interpretation still depends on population, language, setting, and purpose.